DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/Investor Meet20-11-2023
20-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/Investor Meet17-11-2023
Dr Reddy's launches wearable therapy device for migraine
Neriviocan be worn on the upper arm, each device has in-built 18 x 45-minute treatment sessions17-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Results of voting through Postal Ballot and Scrutinizer''s report16-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release/Media release16-11-2023
USFDA flags cleanliness, procedural issues at Dr Reddy's Bachupally unit in Hyderabad
Earlier, Dr Reddy's Laboratories Ltd said the USFDA has issued a Form 483 with 10 observations for its biologics manufacturing facility located in Hyderabad's Bachupally.15-11-2023
Dr. Reddy's Expands Core Business While Venturing Into Innovation In Q2 FY24
Dr. Reddy's reported a significant 33% jump in its consolidated profit after tax (PAT) for Q2 FY24, reaching an impressive $178 million, up from approximately $134 million in the same quarter the previous year14-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of securities of O2 Renewable Energy IX Private Limited10-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Dislcosure Requirements) Regulations, 201509-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificates07-11-2023